These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Nawarskas J; Rajan V; Frishman WH Heart Dis; 2001; 3(6):378-85. PubMed ID: 11975822 [TBL] [Abstract][Full Text] [Related]
26. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor. Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544 [TBL] [Abstract][Full Text] [Related]
27. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs. Farina NK; Johnston CI; Burrell LM J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560 [TBL] [Abstract][Full Text] [Related]
28. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat. Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495 [TBL] [Abstract][Full Text] [Related]
29. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats. Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672 [TBL] [Abstract][Full Text] [Related]
30. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition. Chen HH; Lainchbury JG; Harty GJ; Burnett JC Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932 [TBL] [Abstract][Full Text] [Related]
31. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat. Loch D; Hoey A; Brown L Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344 [TBL] [Abstract][Full Text] [Related]
32. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Ferrario CM; Averill DB; Brosnihan KB; Chappell MC; Iskandar SS; Dean RH; Diz DI Kidney Int; 2002 Oct; 62(4):1349-57. PubMed ID: 12234305 [TBL] [Abstract][Full Text] [Related]
33. Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients. Campese VM; Lasseter KC; Ferrario CM; Smith WB; Ruddy MC; Grim CE; Smith RD; Vargas R; Habashy MF; Vesterqvist O; Delaney CL; Liao WC Hypertension; 2001 Dec; 38(6):1342-8. PubMed ID: 11751715 [TBL] [Abstract][Full Text] [Related]
34. Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Bäcklund T; Palojoki E; Saraste A; Grönholm T; Eriksson A; Lakkisto P; Vuolteenaho O; Nieminen MS; Voipio-Pulkki LM; Laine M; Tikkanen I Cardiovasc Res; 2003 Mar; 57(3):727-37. PubMed ID: 12618234 [TBL] [Abstract][Full Text] [Related]
35. Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: insights from experimental heart failure. Chen HH; Cataliotti A; Burnett JC Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S15-21. PubMed ID: 11716801 [TBL] [Abstract][Full Text] [Related]
38. Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Pu Q; Schiffrin EL Am J Hypertens; 2001 Oct; 14(10):1067-72. PubMed ID: 11710787 [TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans. Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783 [TBL] [Abstract][Full Text] [Related]
40. Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats. Ishimura K; Nishikimi T; Akimoto K; Ono H; Kangawa K; Matsuoka H J Hypertens; 2005 Dec; 23(12):2287-96. PubMed ID: 16269971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]